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Abstract 25 
L-type channel antagonists are of therapeutic benefit in the treatment of 26 
hyperlipidaemia and insulin resistance. Our aim was to identify L-type 27 
voltage gated Ca2+ channels in white fat adipocytes, and determine if they 28 
affect intracellular Ca2+, lipolysis and lipogenesis. We used a 29 
multidisciplinary approach of molecular biology, confocal microscopy, Ca2+ 30 
imaging and metabolic assays, to explore this problem using adipocytes 31 
isolated from adult rat epididymal fat pads. CaV1.2, CaV1.3 and CaV1.1 32 
alpha1, beta and alpha2delta subunits were detected at the gene expression 33 
level. The CaV1.2 and CaV1.3 alpha1 subunits were identified in the plasma 34 
membrane at the protein level. Confocal microscopy with fluorescent 35 
antibodies labelled CaV1.2 in the plasma membrane.  Ca2+ imaging revealed 36 
that the intracellular Ca2+ concentration, [Ca2+]i, was reversibly decreased 37 
by removal of extracellular Ca2+, an effect mimicked by verapamil, 38 
nifedipine and Co2+, all blockers of L-type channels. Whereas the Ca2+ 39 
channel agonist BAY-K8644 increased [Ca2+]i. The finding that the 40 
magnitude of these effects correlated with basal [Ca2+]i suggests that 41 
adipocyte [Ca2+]i is controlled by L-type Ca2+ channels that are 42 
constitutively active at the adipocyte depolarized membrane potential. 43 
Pharmacological manipulation of L-type channel activity modulated both 44 
basal and catecholamine-stimulated lipolysis but not insulin-induced 45 
glucose uptake or lipogenesis. We conclude that white adipocytes have 46 
constitutively active L-type Ca2+ channels which explains sensitivity of 47 
lipolysis to Ca2+ channel modulators. Our data suggest CaV1.2 as a potential 48 






White fat adipocytes (WFA) are the major energy depot of the body, storing 54 
and releasing energy in response to the calorific demands of the body 55 
during periods of excess and need respectively (Arner et al. 2011). It is 56 
widely accepted that an impairment of WFA triglyceride metabolism in 57 
obesity is a major etiological factor of the metabolic syndrome and type 2 58 
diabetes. Whereby the inability of WFA to appropriately store energy as fat 59 
leads to ectopic disposition of lipids in insulin–responsive tissues such as 60 
skeletal muscle, liver and pancreas to promote insulin resistance and 61 
associated systemic disorders (Sattar & Gill 2014). To address 62 
dysfunctional fat storage, it is first necessary to understand the regulation 63 
of lipid storage in healthy WFA.  64 
 65 
Extracellular Ca2+ influx is implicated in the  processes of fat storage 66 
(Arruda & Hotamisligil 2015): lipolysis (Schimmel 1978; Izawa et al. 1983; 67 
Allen & Beck 2000) and lipogenesis (Avasthy et al. 1988). Indeed, studies 68 
in Drosophila mutants indicate that impaired adipocyte cytosolic Ca2+ is 69 
associated with increased lipid deposition (Baumbach et al. 2014). 70 
However, the identity of the Ca2+ pathway  is unclear (Draznin et al. 1988).  71 
 72 
Several routes by which Ca2+ enters primary WFA are identified, these 73 
include voltage-gated Ca2+ channels, VGCC (Clausen & Martin 1977; 74 
Pershadsingh et al. 1989) store-operated Ca2+ channels (El Hachmane & 75 
Olofsson 2018), and reverse mode Na+/Ca2+ exchange, NCX (Pershadsingh 76 
et al. 1989; Bentley et al. 2014). Although VGCCs play a prominent role in 77 
Ca2+ entry and function of electrically excitable cells (Lipscombe 2004), this 78 
route of influx is ill-defined in non-excitable adipocytes.  79 
 80 
Pharmacological investigations show that verapamil and nifedipine, 81 
blockers of L-type VGCCs, can inhibit  WFA Ca2+ uptake (Martin et al. 1975; 82 
Pershadsingh et al. 1989) and impair glucose transport (Draznin et al. 83 
1987), lipolysis (Izawa et al. 1983) and lipogenesis (Avasthy et al. 1988). 84 
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However, this inference of an association between Ca2+ influx and lipid 85 
turnover has come from independent studies where animal species, adipose 86 
depot as well as experimental conditions differed. To date, no 87 
comprehensive synthetic study exists where changes in Ca2+ influx and 88 
WFA function has been examined in primary adipocytes for the same 89 
species under similar experimental conditions of similar age and weight. 90 
Furthermore, a detailed molecular and immunohistochemical investigation 91 
of L-type VGCC expression in WFA is absent. 92 
 93 
The aim of this study was to use a combination of Ca2+ imaging, metabolic, 94 
immunocytochemical and molecular biology techniques to identify L-type 95 
Ca2+ channels in WAT and demonstrate their functional role in lipid 96 
turnover. 97 
 98 
Materials and Methods 99 
 100 
Unless stated otherwise, adipocyte isolation and experiments were 101 
performed in Hank’s buffer solution which composed of (in mM): NaCl 138, 102 
NaHCO3 4.2, KCl 5.6, MgCl2 1.2, CaCl2 2.6, NaH2PO4 1.2, glucose 5 and 103 
HEPES 10 (pH 7.4 with NaOH). For, nominally Ca2+ free solutions, CaCl2 104 
was equimolarly replaced with MgCl2.  All % values are weight per volume. 105 
Unless stated otherwise drugs and chemicals are from Sigma, Poole, UK 106 
 107 
Ethical approval 108 
Animal care and experimental procedures were carried out in accordance 109 
with either the UK Home Office Animals (Scientific Procedures) Act (1986) 110 
or Swedish ethical review board. In both instances the local ethical 111 
committees approved the animal procedures. Animals were killed by 112 
cervical dislocation or CO2. 113 
 114 
Isolation and preparation of adipocytes 115 
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Epididymal fat pads were taken from Wistar rats (fed ad libitum, 12 hr 116 
dark/light cycle, weight 220–420 g; Charles River Laboratory, Kent, UK). 117 
For some experiments tissue from Sprague Dawley rats were used, but 118 
since no difference could be detected, data was pooled. Adipocytes were 119 
isolated as described previously (Bentley et al. 2014).  120 
 121 
PCR  122 
For reverse transcriptase PCR (RT-PCR) total RNA was isolated by cell lysis 123 
in TRI Reagent. Genomic DNA was removed with RQ1 RNase-free DNase 124 
(Promega, UK) with RNA quantity and purity determined by the A260/A280 125 
ratio (1.98 to 2.02). The RNA integrity numbers (6-8) ascertained samples 126 
were suitable for RT-PCR (Schroeder et al. 2006). First-strand cDNA 127 
synthesis used 1 µg of total RNA with 200 ng random hexamer primers and 128 
Avian Myeloblastosis Virus reverse transcriptase (10 units/µl RNA, 129 
Promega).   130 
PCR reactions used Dream Taq PCR Master Mix (ThermoFisher, UK) and 131 
primers shown in Table 1. PCR was performed at 95°C for 10 min, followed 132 
by 40 cycles at 95°C for 45 sec, 58°C for 45 sec, 72°C for 45 sec and 133 
terminated by a final extension step at 72°C for 10 min.  PCR products were 134 
separated on 1% agarose gels, DNA stained with 0.5 μg/ml ethidium 135 
bromide and imaged with GeneSnap software (Syngene, UK). cDNA 136 
sequencing (DeepSeq, Nottingham, UK) checked PCR product identity.  137 
 138 
Quantitative PCR (qPCR) reactions were performed in triplicate with SYBR® 139 
Green JumpStart TM Taq ReadyMix TM. The thermal profile was 10 minutes 140 
at 95°C, 40 cycles of denaturation at 95°C for 15 seconds, annealing for 141 
20 seconds at the primer specific temperature, and elongation at 72°C for 142 
35 seconds. The resultant mean threshold cycle (Ct) values were used for 143 
gene normalization and expression analyses. Three, stable,  reference 144 
genes with the sequences listed in Table 2 were used: glyceraldehyde-3-145 
phosphate dehydrogenase (GAPDH), phosphoglycerate kinase 146 
1 (PGK1) and hypoxanthine guanine phosphoribosyl transferase (HPRT1) 147 
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(Gorzelniak et al. 2001; Fink et al. 2008; Silver et al. 2008). Relative mRNA 148 
levels were quantified by the method of Pfaffl (Pfaffl 2001). 149 
 150 
Western blot analysis 151 
Cytosolic and solubilized plasma membrane proteins were prepared by 152 
differential centrifugation. Cell lysates were prepared at 4°C with a lysis 153 
solution that contained 10 µl of protease inhibitor cocktail per 1 ml of lysis 154 
buffer (10 mM tris, 250 mM sucrose, 1 mM EDTA, pH 7.4). Protein content 155 
was determined by Lowry. 15-20 µg of protein was resolved by SDS-PAGE 156 
on 4-20% gradient precast minigels TGX (Biorad, UK) at 170 volts for 40 157 
minutes. 158 
Protein transfer onto nitrocellulose membranes was performed at 100 volts 159 
for 60 minutes in cold transfer buffer; Ponceau S staining confirmed 160 
transfer. Membranes were blocked in 5% milk in TBST (25mM Tris, pH 7.6; 161 
125 mM NaCl; 0.1% Tween 20) for 3-4 hours, at 20-22°C, followed by 162 
overnight incubation at 4°C with primary antibodies:  rabbit anti-CaV1.3 at  163 
1:200 (ACC-005, Alomone), anti CaV1.2 at 1:500 dilution (ACC-003, 164 
Alomone), anti-β-actin at 1:5,000 and anti-Na,K-ATPase at 1:20,000 165 
(Abcam, UK).  Membranes were washed with TBST and incubated for 1 hour 166 
at room temperature with a 1:10,000 dilution of secondary antibodies: 167 
IRDye 800 CW goat anti-rabbit IgG (Li-COR™) and IRDye 680 CW goat 168 
anti-mouse IgG (Li-COR™). Antibody dilutions were made in 5% milk in 169 
TBST. Membranes were then washed with TBST, rinsed in H2O and imaged 170 
with Li-COR Odyssey infrared Imaging System.  171 
Band intensity was measured using the Li-COR Odyssey software version 172 
2.1 (Li-COR Bioscience, USA) and analyzed using Image Studio Lite Version 173 
5.2. For each protein band the signal intensity was normalized to that of β-174 
actin expression, which was then expressed relative to that in brain. In 175 
initial experiments GAPDH was used as a control, but since comparison of 176 
the ratios obtained with that of β-actin expression showed no difference, 177 
the two set of data were pooled. For CaV1.2 in brain, bands spanning 130-178 
250 kD were combined before normalization to β-actin. Samples probed 179 
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with the primary antibodies in the absence of primary antiserum indicated 180 
absence of non-specific binding 181 
 182 
Immunocytochemistry 183 
Adipocytes were attached to poly-L-lysine (25-100 µg ml-1) coated 184 
coverslips and fixed with 4% PFA for 10 min.  Cells were permeablised in 185 
blocking buffer (PBS with 3% BSA and 0.5% Triton-100x) for 10 min then 186 
stained with primary anti-Calcium Channel L-type alpha 1C subunit 187 
(cacna1C) antibody conjugated with Atto 594 (ACC-003-AG, Alomone,) at 188 
1:200 dilution for 16 hours (Raifman et al. 2017). To visualize nuclei cells 189 
were stained with Hoechst 33342 (8 µM for 30 min). Positive controls were 190 
initially performed with pancreatic beta-cell that express CaV1.2 (Schulla et 191 
al. 2003). Images were captured on a Zeiss LSM880C confocal microscope 192 
with excitation wavelengths of 405nm for Hoechst33342 and 633nm for the 193 
anti-CaV1.2-ATTO antibody. 194 
 195 
Measurement of [Ca2+]i 196 
Adipocytes attached to coverslips were incubated with the Ca2+ fluorophore 197 
Fluo-4 AM (1 M; Molecular Probes) in Hank’s solution with 0.01% BSA for 198 
30 minutes at 21-23C in the dark. Coverslips were mounted in a perifusion 199 
chamber on an Axiovert 135 Inverted microscope equipped for 200 
epifluorescence (Carl Zeiss Ltd, UK). Cells were focused to maximize 201 
equatorial circumference and fluorescence. Adipocytes were identified 202 
under Kohler illumination as 50-100 μm diameter spheroids with a nuclear 203 
protuberance (Fig. 3). Experiments were performed 1-4 hour post isolation. 204 
 205 
Fluo-4 was excited at 450-490 nm, the emitted light band-pass filtered at 206 
515-565 nm and the signal detected using a Photonics Science ISIS-3 207 
camera with image intensification (luminous gain 8,000:1). Fluorescence 208 
emission was integrated for 900 ms and captured at 1Hz with an 8-bit frame 209 
grabber (DT3155, Data Translation, Basingstoke, UK) and Imaging 210 
Workbench Ver. 6.0 software (Indec Biosystems, Santa Clara, CA, USA). 211 
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Cells were perifused at 1 ml min-1. Since dye extrusion occurred at 212 
temperatures >30C, experiments were performed at 27-28C.   213 
 214 
For data analysis, a region of interest (ROI) was drawn around each cell, 215 
background corrected and the time course of its mean fluorescent intensity 216 
calculated. Fluorescence was calibrated by a two-point method (Ni et al. 217 
1994): the maximum fluorescence value, Fmax; determined by 218 
permeabilization of the cells with Triton X-100 (0.0125-0.1%) followed by 219 
10mM EGTA to determine the minimum, Fmin. [Ca2+]i was calculated with 220 








  222 
Where F is the background corrected fluorescence, and Kd the dissociation 223 
constant of Fluo-4: 345 nM (Bentley et al. 2014). Over 75% of basal [Ca2+]i 224 
values measured were below the Kd of the dye and thus within its linear 225 
region of sensitivity. Data was only used from cells in which [Ca2+]i was 226 
stable and had a basal value within the 5-95% percentile range (60-380 227 
nM).  228 
 229 
To visualize spatial variation of [Ca2+]i  it is necessary to mitigate 230 
fluorescent signal heterogeneity due to uneven dye loading or/and 231 
differences in cytoplasmic volume. In the absence of extracellular Ca2+, 232 
Ca2+ influx is abolished and heterogeneity in fluorescence was assumed to 233 
reflect variation in only cell volume and dye loading. Since these 234 
parameters proportionally affect Fluo-4 fluorescence, a ratio of the 235 
fluorescence signal in the presence of extracellular Ca2+ with that in its 236 
absence was undertaken Using ImageJ2 with floating point arithmetic 237 
(Rueden et al. 2017) to normalize these confounders to reveal true 238 
differences in spatial [Ca2+]i.  239 
 240 
Biochemical assays 241 
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To control for differences in adipocyte cell-density, biochemical data were 242 
normalized to paired values measured under basal or control conditions. 243 
Experiments were performed at 37C. 244 
 245 
Free fatty acid assay 246 
Free fatty acid (FFA) release was used to measure lipolysis.  Adipocytes 247 
were incubated for 60 minutes under different experimental conditions in 1 248 
ml of Hank’s. After which, 100 l of supranatant was removed and stored 249 
at -20C prior to assay. FFA was assayed with a non-esterified FFA assay 250 
kit (WAKO chemicals). After subtraction of blank, data was normalized to 251 
the absorbance of the FFA standard (17 M oleic acid) and corrected for 252 
dilution. 253 
 254 
Glucose uptake 255 
Glucose-utilization was measured via 14C glucose uptake. After a 30 minute 256 
pre-incubation under different experimental conditions, 14C glucose was 257 
added and the cells incubated for a further 30 minutes, final volume 0.5 258 
ml. For the assay, cells were separated from the medium by centrifugation 259 
and their 14C content measured via scintillation counting. The GLUT-260 
dependent glucose uptake was determined by subtraction of non-specific 261 
measured in the presence of 10 µM Cytochalasin B. For analysis, 14C uptake 262 
was normalized to that measured in the absence of insulin and drug 263 
additions under control conditions. 264 
 265 
Lipogenesis 266 
Lipogenesis was measured via 3-3H-glucose incorporation. Adipocytes were 267 
incubated for 30 minutes under different experimental conditions with a 268 
fixed activity of 3-3H-glucose. For the assay, cells were separated from the 269 
medium by centrifugation and the 3H content determined via scintillation 270 
counting. Lipogenesis was determined as the difference of cellular counts 271 
to that measured in the absence of 3-3H-glucose. For analysis, lipogenesis 272 
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was normalized to that measured in the absence of insulin and drug 273 
additions under control conditions. 274 
 275 
Justification of drug concentrations employed 276 
Verapamil and nifedipine were used at concentrations employed by others 277 
to block L-type VGCCs in this cell type (Martin et al. 1975; Begum et al. 278 
1992; Ni et al. 1994). Moreover, concentrations were employed to mitigate 279 
their adsorption by serum (>90%) (Rumiantsev et al. 1989) and  280 
absorption by the adipocytes (Louis et al. 2014).  281 
 282 
Statistical analysis 283 
Data were checked with the D'Agostino & Pearson omnibus normality test 284 
with the appropriate inferential test given in the text. Graphical data are 285 
shown as box and whisker plots as median, interquartile range, 10, and 286 
90% confidence intervals. Unless otherwise stated, experiments were 287 
performed as repeated measures. Numerical data are quoted as means  288 
S.E.M. or median with 5 to 95% confidence intervals (95% C.I.), where n 289 
is the number of determinations. Experimental data was collated from at 290 
least four animals. Fitting of equations to data used a least squares 291 
algorithm with the parameters given in text. Statistical analysis was 292 
performed using Graphpad PRISM version 8.2 (San Diego, California USA). 293 
Data were considered statistically significant difference when p < 0.05 and 294 
in graphics is flagged as *, ** when P <0.01, *** when P <0.001 and **** 295 
when P <0.0001. 296 
  297 
  298 
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Results  299 
Molecular Evidence and identification of VGCC in WAT 300 
RT-PCR indicated the presence of mRNA for CaV1.1, CaV1.2 and CaV1.3 but 301 
not CaV1.4 L-type alpha1 subunits in epididymal WFA (Fig. 1A); mRNA for 302 
L-type VGCCs beta2 subunits: cacnb2, cacnb3 and cacnb4, and alpha2delta 303 
subunits, cacna2d1, cacna2d2 and cacna2d3 were also detected. cDNA 304 
sequence analysis of the PCR products for CaV1.1, CaV1.2 and CaV1.3 gave 305 
98.7±0.3 (n=3), 98.5±0.2% (n=6) and 97.8±0.7% (n=6) identity to the 306 
rat VGCC subunits alpha1S (Cacna1s), alpha1C (Cacna1c) and alpha1D 307 
(Cacna1d) respectively. Quantification of mRNA levels by qPCR gave a rank 308 
expression order of CaV1.2 > CaV1.3 > CaV1.1 (Fig. 1B).  309 
  310 
Western blots of the plasma membrane fraction revealed a 260 kD CaV1.3 311 
alpha-subunit (Fig. 2B) (N’Gouemo et al. 2015) and an extended form of 312 
CaV1.2 of>250 kD (Fig. 2A); the latter bigger than the canonical neuronal 313 
isoform of 210 kD (Raifman et al. 2017). CaV1.2 protein expression was 10 314 
fold greater than that of CaV1.3 (Fig. 2C; p<0.001, Mann Whitney); a ratio 315 
comparable the qPCR results (Fig. 1B)  316 
 317 
Immunohistochemical evidence of VGCC in WAT 318 
Confocal microscopy revealed that fixed adipocytes preserved their 319 
morphology (Fig. 3A) as demonstrated by retention of their nucleus and 320 
spherical form. Atto 594 labeled antibodies identified CaV1.2 in the plasma 321 
membrane; this was granular in appearance and densest near the nucleus 322 
(Fig. 3B). Given this finding, the spatial distribution of [Ca2+]i was examined 323 
(Fig. 3C).  Figure 3C shows six adipocytes with identifiable nuclei, all of 324 
which responded with a reversible decrease in [Ca2+]i on removal of bath 325 
Ca2+ (Fig. 5A). Although the change in [Ca2+]i was uniformly distributed in 326 
the extra-nuclear cell membrane for all six cells, three had a higher [Ca2+]i 327 
in the perinuclear region (Fig. 3D); data which supports a higher density of 328 
VGCCs in this region.  329 
 330 
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Evidence for constitutive Ca2+ influx  331 
Epifluorescent imaging of adherent adipocytes revealed a skewed basal 332 
[Ca2+]i and Gaussian cell diameter distributions with median values of 135 333 
nM (129 to 145 nM, 95% C.I., n = 555) and 80 µm (79 to 81 µm, 95% 334 
C.I., n = 580) respectively (Fig. 4A, B). [Ca2+]i values are similar to those 335 
previously reported (Schwartz et al. 1991; Hardy et al. 1992; Ni et al. 1994; 336 
Gaur et al. 1998). 337 
 338 
Both basal [Ca2+]i (Spearman r = 0.17, 0.084 to 0.25 95% C.I.,  p < 339 
0.0001, Fig. 4C)  and body weight (Spearman r = 0.13, 0.01 to 0.26 95% 340 
C.I., p < 0.05, Fig. 4D) were positively correlated with adipocyte diameter,  341 
although  [Ca2+]i did not correlate with individual animal weight (Spearman, 342 
Fig. 4E).  343 
 344 
To explore Ca2+ influx, the effect of equimolar substitution of extracellular 345 
Ca2+ with Mg2+ was investigated. Removal of bath Ca2+ reversibly 346 
decreased [Ca2+]i, Δ[Ca2+]i, by 30% (25 to 34%, 95% C.I ; p<0.0001, 347 
Friedman; Figs. 5A, B). Δ[Ca2+]i was negatively correlated with basal 348 
[Ca2+]i: that is cells with the highest basal values underwent the largest 349 
percentage decrease on Ca2+ removal (Spearman r = -0.32, P<0.001; Fig. 350 
5C). Δ[Ca2+]i, was unrelated to cell diameter or body weight (Spearman). 351 
Prolonged exposure to Ca2+ removal for over three hours did not affect cell 352 
integrity which suggest that this intervention is not cytotoxic. 353 
 354 
Doubling the extracellular Ca2+ concentration produced a 9% increase in 355 
[Ca2+]i (4 to 16%, 95% C.I; p<0.0001 Wilcoxon Signed Rank; Figs. 5D, E). 356 
Conversely, addition of 2.5 mM Co2+, an inorganic inhibitor of VGCCs, 357 
irreversibly decreased [Ca2+]i by 13% (8 to 17%, 95% C.I; p<0.0001 358 
Wilcoxon Signed Rank; Fig. 5D); a magnitude  comparable to that seen 359 
with removal of extracellular Ca2+ (Fig. 5E).  360 
 361 
Pharmacological manipulation of Ca2+ influx 362 
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We next tested a variety of pharmacological agents that affect VGCC 363 
activity. Although both verapamil and nifedipine significantly decreased 364 
[Ca2+]i relative to DMSO control (Fig. 6) (p<0.001 and p<0.0001 365 
respectively, Wilcoxon Signed Rank), the effect of nifedipine was small 366 
(Figs. 6B, F). Verapamil decreased Δ[Ca2+]i to a similar extent to Ca2+ 367 
removal (Kruskal Wallis, Fig. 6F). In the presence of nifedipine Ca2+ 368 
removal further decreased [Ca2+]i (Figs. 6B, G). In any given cell, the 369 
amount by which verapamil decreased [Ca2+]i positively correlated with 370 
that seen with extracellular Ca2+ removal (Pearson r = 0.77, slope 0.66 ± 371 
0.13, p<0.001; Fig. 6H). 372 
 373 
We next explored the pharmacology of [Ca2+]i recovery following re-374 
addition of Ca2+ to the bath after its removal. Both verapamil (Figs. 7B, F, 375 
J) and nifedipine (Figs. 7C, G, J) significantly affected [Ca2+]i recovery 376 
(Figs. 7A, E, J); did. The NCX inhibitor SN-6 neither affected basal [Ca2+]i 377 
or its recovery (Figs. 7H, J). BAY-K8644, an agonist of L-type VGCCs, 378 
significantly enhanced recovery (Figs. 7D, I, J). 379 
 380 
L-type Ca2+ influx stimulates basal lipolysis  381 
Since Ca2+ modulates the lipolytic cascade in WFA (Schimmel 1978; Izawa 382 
et al. 1983; Allen & Beck 2000), we investigated if L-type VGCCs affected 383 
lipolysis (Fig. 9). Isoprenaline stimulated lipolysis with a pEC50 of 7 (6.7 to 384 
7.3, 95% C.I) and Hill coefficient of 0.8 (0.43 to 1.2, 95% C.I; Fig. 9A). At 385 
10 µM, isoprenaline stimulated lipolysis 9.8 ± 0.63 fold (p<0.001, One 386 
Sample t test; n = 39). Consistent with previous reports (Izawa et al. 1983; 387 
Allen & Beck 2000), removal of extracellular Ca2+ neither affected the EC50 388 
or Hill coefficient for isoprenaline, but decreased lipolysis by ~30% 389 
(p<0.0004; Figs. 8A, C). Insulin inhibited the beta-adrenoceptor stimulated 390 
lipolysis with a pEC50 of 9.4 (9.6 to 9.3, 95% C.I; Fig. 9B). 391 
 392 
Interventions that promoted Ca2+ influx: BAY-K8644 or elevation of [K+]o 393 
(Bentley et al. 2014), stimulated basal, but not isoprenaline-stimulated, 394 
 14
lipolysis (Figs. 8C, D). Interventions that decreased Ca2+ influx: removal of 395 
extracellular Ca2+ or verapamil inhibited both isoprenaline-stimulated and 396 
basal lipolysis (Fig. 8C, D). Insulin stimulated basal lipolysis (Fig. 8D), an 397 
effect consistent with its ability to elevate [Ca2+]i (Clausen & Martin 1977). 398 
The capacity of 20 nM insulin to block beta-adrenoceptor stimulated 399 
lipolysis was unaffected by interventions that affected [Ca2+]i (Fig. 8E).  400 
 401 
We checked if intracellular Ca2+ handling affected lipolysis. 1 µM oxytocin, 402 
which mobilizes intracellular Ca2+ (Kelly et al. 1989), did not affect basal 403 
lipolysis (Fig. 8G), but consistent  with others  (Fain et al. 1997) inhibited 404 
isoprenaline-stimulated lipolysis (Fig. 8F). Neither store depletion with 1 405 
µM thapsigargin (El Hachmane et al. 2018), or increased cytosolic Ca2+ 406 
buffering with 10 µM BAPTA-AM (Komai <i>et al.</i> 2014)affected 407 
isoprenaline-stimulated lipolysis Fig. 8F); however, both treatments 408 
impaired basal lipolysis (Fig. 8G); actions consistent with the greater 409 
sensitivity of basal lipolysis to [Ca2+]i compared to that stimulated by 410 
isoprenaline (Figs. 8C, D). 411 
  412 
Although alpha-adrenoceptor activation mobilizes intracellular Ca2+ stores 413 
in WFA (Hardy et al. 1992), like others (Blackmore, PF;Augert 1989; 414 
Seydoux et al. 1996), we did not see an increase in [Ca2+]I with beta-415 
adrenoceptor activation (n = 7). 416 
 417 
L-type Ca2+ influx does not affect glucose uptake or lipogenesis 418 
Insulin at 2 nM maximally stimulated glucose uptake 5 fold (p<0.001, One 419 
Sample t test) (Fig. 9A). Insulin–stimulated glucose uptake was unaffected 420 
by either 5 µM nifedipine or 1 µM BAY-K8644 (Figs. 9A, B); outcomes that 421 
were independent of insulin concentration. Lipogenesis was also maximally 422 
stimulated by 2 nM insulin (~9 fold, p<0.001, One Sample t test) (Figs. 423 
10C, D). However, neither 5 µM nifedipine or 1 µM BAY-K8644 significantly 424 
affected lipogenesis (Figs. 10C, D). 425 
 426 
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Molecular evidence for L-type Ca2+ channels 430 
Our Western blot, PCR and in-situ immunolabelling data demonstrates 431 
expression of CaV1.2 and CaV1.3 L-type VGCCs in primary white fat 432 
adipocytes. The presence of CaV1.2/CaV1.3 in WFA is consistent with 433 
transcriptomic data published for human (Fagerberg et al. 2014) and 434 
mouse fat tissue (Yue et al. 2014); however, in contrast to these, we failed 435 
to detect CaV1.4. Although the 250 kD CaV1.2 protein band went undetected 436 
in our brain tissue control we did detect its 210 KD proteolytic cleavage 437 
product (Hell et al. 2017; Shi et al. 2017). Using the same antibody, others 438 
have also detected just a 210 kD CaV1.2 band (N’Gouemo et al. 2015). The 439 
140 kD band may relate to the 130 kD or 150 kD non-Cav1.2 epitope that 440 
this antibody recognized in CaV1.2 knock out mice (Bavley et al. 2017; Hell 441 
et al. 2017). Though adipocytes possessed a CaV1.2 immuno-positive band, 442 
they did not show any further proteolytic cleavage products, data that 443 
suggests that this protein has post-translational modification with a 444 
polymorphic proteolytic cleavage site. For CaV1.3, we only obtained positive 445 
immunoblots with early batches of antibody, a recognized problem with 446 
commercial antibodies to CaV1.3 (Hell et al. 2017). In WFA,  CaV1.3 was 447 
comparable in molecular weight to that observed in our brain controls and 448 
heart (268kD) (Le Scouarnec et al. 2008). The presence of mRNA for L-449 
type VGCC alpha1, beta2 and alpha2delta subunits suggests that adipocytes 450 
have the capacity to traffic and assemble functional VGCCs (Dolphin 2016). 451 
 452 
Constitutive Ca2+ influx through L-type Ca2+ channels. 453 
Our finding that both Co2+ and verapamil decreased [Ca2+]i by similar 454 
amounts to Ca2+ removal is indicative of a Ca2+-influx pathway mediated 455 
by L-type VGCCs. This notion is reinforced by enhancement of Ca2+ influx 456 
by the L-type VGCCs dihydropyridine agonist BAY-K8644. Our data 457 
contrasts to studies where neither nitrendipine or verapamil affected [Ca2+]i 458 
under basal conditions (Gaur et al. 1996a, b). One possible reason for this 459 
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discrepancy is that we corrected for the effect of DMSO on fluorescence to 460 
reveal a block whereas previous studies had not.  461 
The fact that removal of bath Ca2+ had a larger effect in adipocytes with 462 
higher basal [Ca2+]i suggests that basal [Ca2+]i is set by the prevalent VGCC 463 
activity. These findings, combined with the ability of verapamil and 464 
nifedipine to prevent, and BAY-K8644 to enhance Ca2+ recovery, suggest 465 
that basal [Ca2+]i in WFA is maintained by a constitutive Ca2+ influx via L-466 
type VGCCs; an idea supported by impairment of  45Ca2+ uptake in WFA by 467 
L-type VGCCs antagonists (Martin et al. 1975). 468 
 469 
The resting membrane potential of primary white adipocytes, measured by 470 
ourselves (Bentley et al. 2014) and others (Ramírez-Ponce et al. 1990; Lee 471 
& Pappone 1997), is around -30 mV. As this voltage is within the activation 472 
range of L-type VGCCs (Xu & Lipscombe 2001) a  “window Ca2+ current” 473 
(Fleischmann et al. 1994) is expected. Constitutive L-type VGCC activity in 474 
electrically non-excitable cells is not unique; for example it has been 475 
recorded at a similar Vm (-30 mV) in osteoclasts (Miyauchi et al. 1990). To 476 
be constitutively active, inactivation of these VGCCs must be incomplete. 477 
 478 
Although whole-cell voltage-clamp would have been ideal for 479 
electrophysiological characterization of the VGCCs we did not attempt this 480 
for technical reasons. First, the adipocyte cytoplasm is a relatively thin ~0.3 481 
µm layer wrapped around a lipid droplet of ~80 µm diameter (Bentley et 482 
al. 2014); this creates a membrane time constant of 100’s of ms (Bentley 483 
et al. 2014), compared to ~2 ms for a neuron (Coombs et al. 1956) of 484 
similar diameter (Henneman & Mendell 2010). This difference precludes 485 
voltage-clamping of VGCCs under physiological conditions due to space 486 
clamp considerations and “voltage escape” (Armstrong & Gilly 1992). 487 
Secondly, although Ca2+ influx can affect [Ca2+]i, we have previously shown 488 
that it is too small to affect Vm (Bentley et al. 2014),  a result indicative of 489 
low channel density. Indeed, 45Ca2+ tracer studies (Martin et al. 1975) have 490 
measured the DHP-sensitive Ca2+ influx in WFA at ~0.024 pmoles s-1 cm-2: 491 
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~1.5 amoles s-1 cell-1 or ~ 0.3 pA of whole-cell inward Ca2+ current, a value 492 
too low to measure with whole-cell voltage-clamp.  493 
 494 
Constitutive Ca2+ influx modulates lipid metabolism 495 
Our data confirms that both basal and stimulated lipolysis require 496 
extracellular Ca2+ (Bleicher et al. 1966; Ziegler et al. 1980; Allen & Beck 497 
2000). However, we now show that lipolysis is sensitive to agents that 498 
modulate L-type VGCC activity. Although, isoprenaline-stimulated lipolysis 499 
could not be enhanced by interventions that increase [Ca2+]i, presumably 500 
because it was already maximal, like basal lipolysis, it was impaired by 501 
verapamil and Ca2+ removal. The idea that  Ca2+-influx promotes lipolysis 502 
is also supported by the action of high K+, where substitution of bath Na+ 503 
with K+ elevates [Ca2+]i by reverse Na+-Ca2+ exchange (Bentley et al. 504 
2014). 505 
 506 
Multiple targets exist for extracellular Ca2+ during beta-adrenoceptor 507 
stimulated lipolysis. Extracellular Ca2+ enhances beta-adrenoceptor 508 
stimulated cAMP production (Ziegler et al. 1980) and is also  required for 509 
undefined lipolytic processes downstream of cytosolic cAMP (Allen & Beck 510 
2000). Indeed, lipolysis can be potentiated by increasing [Ca2+]i with Ca2+ 511 
ionophores in the absence of cAMP elevation (Gaion & Krishna 1982) or 512 
conversely, as shown here, depressed with Ca2+ chelators (Efendić et al. 513 
1970). However, the exact mechanisms by which Ca2+, and indeed Ca2+ 514 
influx modulates basal lipolysis remains unknown; it  is unlikely to involve 515 
the Ca2+-sensitive, isoform III, of adenylyl cyclase found in WFA (Wang et 516 
al. 2009) since changes in Ca2+ influx do not  affect adipocyte cAMP levels 517 
under basal conditions (Ziegler et al. 1980). However, adipocyte lipoprotein 518 
lipase is positively  modulated by Ca2+ (Efendić et al. 1970; Soma et al. 519 
1989; Carmen & Víctor 2006). 520 
 521 
Translational context 522 
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The idea that Ca2+ influx via CaV1.2/CaV1.3 regulates basal lipolysis agrees 523 
with translational data. Rats with chronic renal failure are hyperlipidaemic 524 
and possess WFA with elevated intracellular Ca2+ levels (Ni et al. 1995). 525 
The observation that verapamil reversed these phenomena suggests that 526 
exacerbated Ca2-influx via L-type VGCCs may be responsible for the 527 
elevated basal lipolysis. This notion is also supported by the ability of 528 
nicardipine to decrease plasma levels of FFA in spontaneously hypertensive 529 
rats (Cignarella 1994). Moreover, in humans, verapamil can also decrease 530 
basal plasma FFA levels, again data suggestive of VGCC mediated Ca2-531 
influx dependent lipolysis (Hvarfner et al. 1988). Such effects do not arise 532 
through impairment of beta-adrenoceptor activation since 533 
antihypertensives such as nicardipine and verapamil actually promote 534 
catecholamine levels through activation of baroreflex mediated 535 
sympathetic output. The failure of the DHP L-type channel antagonists to 536 
affect plasma FFA in man can be reconciled by the binding of these drugs 537 
to Cav1.2/1.3 being compromised by FFA (Pepe et al. 2006).  538 
 539 
Conclusion 540 
Our study provides direct, corroborative, evidence for the existence of 541 
CaV1.2/CaV1.3 L-type voltage-gated Ca2+ channels in white adipocytes. The 542 
basal concentration of intracellular Ca2+ appears to reflect the ambient level 543 
of VGCC activity on an individual cell basis, apparently unrelated to 544 
adipocyte size or animal weight. Importantly, CaV1.x channels contribute 545 
to a persistent state of Ca2+ influx in WFA, without the need for cell 546 
excitability, and appear to have a key role in lipolysis.  Consequently, 547 
dysregulation of CaV1.x in WFA may contribute to lipid storage disorders 548 
that may contribute to, or indeed precipitate, the metabolic syndrome. As 549 
such, these cation channels may be a potential therapeutic target for the 550 
treatment of hyperlipidaemia, peripheral insulin resistance and obesity. 551 
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Beta-actin V01217 FWD: 5'-AGGCCCAGAGCAAGAGAG-3'  
REV: 5'-CCTCATAGATGGGCACAGT-3’ 
333 




















U31816.1 FWD: 5'- AGCACAAGACCGTAGTGGTG-3'  
REV: 5'- ATACCCCCAATGCCACACAG-3’ 
168 
Cacnb1 NM_017346.1 FWD: 5’-AGTGCCAACAGAAGCAGAAGT-3’ 
REV: 5’-GTGTTTGCTGGGGTTGTTGAG-3’ 
237 
Cacnb2 NM_053851.1 FWD: 5’-CTCTTCTTCCCCTGCACCAA-3’ 
REV: 5’-GCCTCGGCTAAGAGCAGTTT-3’ 
237 
Cacnb3 NM_012828 FWD: 5’-CCTACGCCCGGGTTTGA-3’ 
REV: 5’-CAAATGCCACAGGTTTGTGCT-3’ 
174 
Cacnb4 NM_001105733.1 FWD: 5’-ATGCCAGGTCTGCATGTCTC-3’ 
REV: 5’-ACATGGGGGTCTGGTGATCC-3’ 
231 
Cacna2d1 NM_012919.3 FED: 5’-CCAAATCTCAGGAGCCGGT-3’ 
REV: 5’-GCAATACCAAGGCCAAACTGT-3’ 
219 
Cacna2d2 NM_175592.2 FWD: 5’-CTGCAGGTCAAGTTGCCAAT -3’ 
REV: 5’-AGACGCGTTCCACTAACTGC -3’ 
262 
Cacna2d3 NM_175595 FWD: 5’-TGGACGAGAGGCTGCTTTTG-3’ 
REV: 5’-ATGTACGCTTCGGTCCACAC-3’ 
180 





Table 2. Primer sequences used for qPCR analysis 814 
Name Sequence Product Size 
(bp) 
Hprt1 FWD:5'- CGAGGAGTCCTGTTGATGTTGC -3'  
REV:5'- CTGGCCTATAGGCTCATAGTGC -3’ 
172 
Pgk1 FWD:5'- TAGTGGCTGAGATGTGGCACAG -3'  
REV:5'- GCTCACTTCCTTTCTCAGGCAG -3' 
166 
GAPDH FWD:5'- GGCAAGTTCAATGGCACAGT -3  
REV:5'- TGGTGAAGACGCCAGTAGACTC -3' 
183 





Figure 1. CaV1.1, 1.2 and 1.3 mRNA are expressed in rat 819 
adipocytes. A) RT-CPR products (Rattus norvegicus) of voltage-dependent 820 
L-type calcium channels CaV1.1, CaV1.2, CaV1.3 and CaV1.4 alpha1 821 
(cacna1s, cacna1c, cacna1d and cacna1f), beta2 (cacnb1, cacnb2, cacnb3 822 
and cacnb4) and alpha2delta (cacna2d1, cacna2d2, cacna2d3 and 823 
cacna2d4) subunits for white fat adipocytes and for control: skeletal muscle 824 
for cacna1s (CaV1.1) and whole brain for all other genes; L , DNA 50 bp 825 
ladder. PCR product sizes are in Table 1. B) Relative expression of CaV1.1, 826 
CaV1.2 and CaV1.3 alpha-1 subunits as determined by qPCR. Data is 827 
normalized to mRNA expression of CaV1.2 in rat brain. Each point 828 
represents a different animal (n=10), horizontal line is mean. Statistical 829 
significance is by one-way ANOVA, with Tukey’s multiple comparison test. 830 


























Figure 2.  White fat adipocytes express CaV1.2 and CaV1.3 protein 833 
in membrane fractions. Representative Western blots of CaV1.2 (A) and 834 
CaV1.3 (B) in adipocyte cell lysate fraction (ACF) and membrane fraction 835 
(AM) of white fat adipocytes. Note the larger molecular weight (MW) of the 836 
CaV1.2 protein in adipocytes: >250 kD compared to the proteolytic 837 
cleavage product of 210 kD in the whole brain cell lysate (BCL) positive 838 
control. C) Relative protein expression of CaV1.2 (n=5) to CaV1.3 (n=9) in 839 
membrane fractions from white fat adipocytes. Data normalized to beta-840 
actin. Horizontal lines are the medians. Statistical significance is by Mann 841 









































Figure 3. CaV1.2 in the plasma-membrane. A and B Confocal images of 846 
fixed rat epididymal white fat adipocytes. A) Blue, nucleus stained with 847 
Hoechst 33342; Magenta, Atto 594 labelled antibody to CaV1.2. Image 848 
captured over 62s. B) Magenta only channel to highlight CaV1.2 labelling 849 
which is densest in the nuclear region. Arrows indicate associated nuclei.  850 
C and D greyscale epifluorescent Ca2+ images of a field of 6 rat epididymal 851 
white fat adipocytes. C) Adipocytes under basal conditions, arrows indicate 852 
nuclei. Note nuclear protuberances and brighter circumferential 853 
fluorescence where the cytoplasm has the deepest volume parallel to the 854 
plane of illumination. D) Image shown in C is ratioed to that observed in 855 
the absence of extracellular Ca2+ to normalize dye loading and cytoplasmic 856 
volume. The brighter fluorescence in the perinuclear region of cells i, ii, and 857 













Figure 4. Measurement of intracellular [Ca2+]i in isolated adipocytes 864 
A) Distribution of  basal [Ca2+]i (n = 588). B) Distribution of adipocyte 865 
diameters (n = 547). C) Scatter plot of [Ca2+]i versus cell diameter (n= 866 
495). D) Scatter plot of cell diameter for 233 adipocytes with each vertical 867 
data set taken from a given weighed animal (45 in total). Solid lines in C) 868 
& D) are drawn by linear regression with slopes of 0.65 ± 0.29 nM µM-1 (p< 869 
0.03) and 0.058 ± 0.02 µm g-1 (p < 0.01 ) respectively. Dotted lines are 870 
95% C.I. for the fits shown. E) Individual distributions of basal [Ca2+]i for 871 
epididymal adipocytes from 13 different rats (n = 7-40). Note the variation 872 
in [Ca2+]i within any given animal was greater than between animals 873 
(ANOVA). 874 
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Figure 5.  Extracellular Ca2+ removal decreases intracellular 878 
[Ca2+]i A) [Ca2+]i time courses measured for 6 adipocytes within a single 879 
field in response to removal of bath Ca2+ (Ca-free),  followed by 0.1% 880 
DMSO. B) [Ca2+]i in control (Ctrl), after removal of extracellular Ca2+ (Ca-881 
free) and recovery (Wash) (n = 138). Statistical inference by Friedman with 882 
Dunn’s multiple comparison tests.  C) Relationship between the decrease 883 
in [Ca2+]i, Δ[Ca2+]i, on removal of bath  Ca2+and basal [Ca2+]i. Solid line 884 
drawn by linear regression with a slope of -0.17 ± 0.01 % nM-1 (p< 885 



























































course of [Ca2+]i for 5 adipocytes in response to 5 mM CaCl2 (HiCa) followed 887 
by 2.5 mM CoCl2 (Cobalt) added to the bath. E) Δ[Ca2+]i responses to HiCa 888 
(n = 17), Cobalt (n = 19) and removal of extracellular Ca2+ (Ca-free; n = 889 
140). Dashed line indicates no effect. Data is from 7 animals. Statistical 890 
inference was by Kruskal-Wallis with Dunn’s multiple comparison tests.   891 
  892 
 37
893 
Figure 6.  Verapamil and nifedipine decrease the intracellular Ca2+ 894 
concentration, [Ca2+]I A) Mean time course of [Ca2+]i measured for 11 895 
adipocytes within a single field in response to removal of bath Ca2+ (Caf),  896 
followed by 20 µM verapamil (V). B) Mean time course of [Ca2+]i measured 897 
for a field of 5 adipocytes in response to removal of bath Ca2+ (Cafr) in the 898 


























































































































absence and then presence of 20 µM nifedipine (Nif). Note block by 899 
nifedipine is countered by a positive DMSO effect on fluorescence. C) [Ca2+]i 900 
in control (Ctrl), after removal of extracellular Ca2+ (Ca-free) and recovery 901 
(Wash) followed by 20 µM verapamil (Ver) (n= 19 from 6 animals). D) 902 
[Ca2+]i in control (Ctrl), after removal of extracellular Ca2+ (Ca-free) and 903 
recovery (Wash) followed by the addition of 20 µM nifedipine (Nif) (n = 15 904 
from 4 animals). E) [Ca2+]i in control (Ctrl), after removal of extracellular 905 
Ca2+ (Ca-free) and recovery (Wash) followed by 0.1% DMSO (n = 36 from 906 
6 animals). F) Comparison of Δ[Ca2+]i produced by removal of bath Ca2+ 907 
(Ca-free), 20 µM nifedipine (Nif; n = 15) and 20 µM verapamil (Ver; n = 908 
19). Data are from C and D and are corrected for DMSO effects shown in E 909 
(n = 137). G) [Ca2+]i in the continuous presence of 20 µM nifedipine (Nif1) 910 
where Ca2+ is removed from the bath (Nif Ca-free) and added back again 911 
(Nif2) (n= 9 from 2 animals). For C-G, statistical comparison between 912 
groups was by Kruskal-Wallis with Dunn’s multiple comparison tests. H) 913 
Relationship between Δ[Ca2+]i produced by 20 µM verapamil and removal 914 
of bath Ca2+ (n = 21) for the same cell. Solid line is linear regression of 915 
data with a slope of 0.66 ± 0.13. The dotted lines are the 95% C.I. of the 916 
fit.   917 
  918 
 39
919 
Figure 7. Pharmacological exploration of Ca2+ recovery. A-D) 920 
Representative mean time courses of [Ca2+]i in response to removal of bath 921 
Ca2+ (Ca-free)  followed by the addition of drugs as indicated.: A) 0.1% 922 
vovl/vol DMSO; B) 20 µM verapamil (V);  C) 20 µM nifedipine (Nif); D) 10 923 
µM  BAY-K8644 (BAYK) all in Ca2+ free. E) [Ca2+]i in control (Ctrl), after 924 
 40
removal of extracellular Ca2+ (Ca-free), after addition of 0.1% DMSO (Ca-925 
fDMSO), then re-addition of bath Ca2+ in the presence of DMSO (DMSO) (n 926 
= 19 from 12 animals). F) [Ca2+]i in control (Ctrl), after removal of 927 
extracellular Ca2+ (Ca-free), followed by 20 µM verapamil in Ca2+ free (Ca-928 
fVer), then re-addition of bath Ca2+ in verapamil (Ver) (n = 67 from 12 929 
animals). G) [Ca2+]i in control (Ctrl), after removal of extracellular Ca2+ 930 
(Ca-free), followed by 20 µM nifedipine in Ca2+ free (Ca-fNif), then re-931 
addition of bath Ca2+ in nifedipine (Nif) (n = 33 from 6 animals). H) [Ca2+]i 932 
in control (Ctrl), after removal of extracellular Ca2+ (Ca-free), followed by 933 
10 µM SN6 in Ca2+ free (Ca-fSN6), then re-addition of bath Ca2+ in SN6 934 
(SN6) (n = 18 from 5 animals). I) [Ca2+]i in control (Ctrl), after removal of 935 
extracellular Ca2+ (Ca-free), followed by 10 µM  BAY-K8644 in Ca2+ free 936 
(Ca-fBAYK), then re-addition of bath Ca2+ in BAY-K8644  (BAYK) (n = 18 937 
from 8 animals). All data uncorrected for DMSO effect.  J) Percentage 938 
change in basal [Ca2+]i after recovery on re-addition of bath Ca2+ with the 939 
various treatments as shown. Statistical comparison was by Friedman with 940 
Dunn’s multiple comparison multiple comparison. 941 
.  942 
 943 







Figure 8.  Extracellular Ca2+-influx potentiates lipolysis. A) Lipolysis 950 
as a function of isoprenaline in the presence () and absence () of bath 951 
Ca2+. Solid lines are fits of the data with sigmoidal dose response curves 952 
with parameters given in the text. Data means ± S.E.M (n = 4-5). B) 953 
Inhibition of lipolysis by insulin. Solid line is a fit of the data to dose-954 
response curve with parameters given in the text. Data are means ± S.E.M 955 
(n = 5-9). C) Effects of interventions on lipolysis stimulated by 10 µM 956 
isoprenaline: Ca free, removal of bath Ca2+; Ver,  5 µM verapamil; Nif, 20 957 
µM nifedipine; Ins, 20 nM insulin; BAYK, 1 µM  BAY-K8644; HiK, 50 mM 958 
bath [K+]o (n = 6–16). D) Effects of interventions on basal lipolysis. Key as 959 
for C (n = 6–16). E) Effects of interventions on beta-adrenoceptor mediated 960 
lipolysis inhibited by 20 nM insulin: Key as for C (n = 6–10). F) Effects of 961 
interventions on 10 µM isoprenaline stimulated lipolysis: OXY, 1 µM 962 












































































































































oxytocin; THAP, 10 µM thapsigargin; BAPTA, 10 µM BAPTA-AM (n = 9–21). 963 
G) Effects of interventions as  shown in F on basal lipolysis. (n = 6–10). 964 
DMSO the solvent for verapamil, nifedipine, and BAY-K8644 was without 965 
effect on lipolysis. Statistics are Wilcoxon Sign test relative to 100%.  966 
 967 




Figure 9.  Ca2+-influx via L–Type VGCC does not affect glucose 971 
uptake and lipogenesis. A) Effect of 5 µM nifedipine on glucose uptake. 972 
B) Effect of 1 µM BAY-K 8644 on glucose uptake. C) Effect of 5 µM nifedipine 973 
on lipogenesis. D) Effect of 1 µM  BAY-K 8644 on lipogenesis. Drug additions 974 
are indicated by filled bars, controls by open bars, conditions are as 975 
indicated. Ins, insulin, glu, glucose. Data are all paired with n=5 for each 976 
condition. Statistical inference by Friedman’s test. 977 
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